SCHEMBL32688269

SCHEMBL32688269

N#Cc1c(SCc2nnn[nH]2)[nH]c(=O)c(C#N)c1-c1ccc(-c2ccc(Cl)cc2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSD11B1 P28845 6/20 0.45
▸ IDO1 P14902 1/20 0.43
▸ MEN1 O00255 3/20 0.40
▸ KMT2A Q03164 3/20 0.40
▸ LMNA P02545 2/20 0.40
▸ POLB P06746 2/20 0.40
▸ ACMSD Q8TDX5 1/20 0.39
▸ CXCR2 P25025 1/20 0.39
▸ KDM4E B2RXH2 3/20 0.38
▸ ALDH1A1 P00352 2/20 0.38
▸ NPSR1 Q6W5P4 2/20 0.38
▸ RXFP1 Q9HBX9 2/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ LDHA P00338 2/20 0.38
▸ GLA P06280 2/20 0.37
▸ GAA P10253 2/20 0.37
▸ PIM1 P11309 1/20 0.37
▸ ATM Q13315 1/20 0.37
▸ HPGD P15428 1/20 0.36
▸ CRHBP P24387 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32688136 0.92 HSD11B1 (0.41) HSD11B1IDO1MEN1KMT2ALMNA
SCHEMBL32688008 0.92 MEN1 (0.42) HSD11B1IDO1MEN1KMT2APOLB
SCHEMBL32688166 0.92 HSD11B1 (0.41) HSD11B1IDO1MEN1KMT2A
SCHEMBL32688160 0.91 HSD11B1 (0.36) HSD11B1IDO1
SCHEMBL32688034 0.91 PDE9A (0.43) MEN1KMT2APOLBCXCR2KDM4E
SCHEMBL32688201 0.89 HSD11B1 (0.36) HSD11B1IDO1CXCR2
SCHEMBL32688250 0.89 HSD11B1 (0.41) HSD11B1IDO1MEN1KMT2ALMNA
SCHEMBL32688235 0.89 HSD11B1 (0.45) HSD11B1IDO1MEN1KMT2ALMNA
SCHEMBL32688289 0.88 ADORA1 (0.40) HSD11B1MEN1KMT2ALMNAPOLB
SCHEMBL32688432 0.88 ADORA1 (0.40) HSD11B1IDO1MEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260078105-A1 Novel Aminocarboxymuconate Semialdehyde Decarboxylase Inhibitors ORSOBIO INC (US) 2026-03-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260078105-A1 Novel Aminocarboxymuconate Semialdehyde Decarboxylase Inhibitors CPT1B, CBR1, MUSK HSD11B1 61/4885IDO1 1284/4885MEN1 4353/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback